Stay updated with breaking news from Cell Forge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics, Inc. (NASDAQ:NASDAQ:ALLO) Q1 2022 Earnings Conference Call May 04, 2022 05:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang...
FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, April 21, 2022 /PRNewswire/ -- Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide
/PRNewswire/ -- Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance infections. If solutions...
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company...
ALLO earnings call for the period ending September 30, 2021.